Allogeneic hematopoietic cell transplantation outcomes in patients with Richter's transformation
Haematologica
.
2021 Dec 1;106(12):3219-3222.
doi: 10.3324/haematol.2021.279033.
Authors
Haesook T Kim
1
,
Peter O Baker
2
,
Erin Parry
2
,
Matthew Davids
2
,
Edwin P Alyea
3
,
Vincent T Ho
2
,
Corey Cutler
2
,
John Koreth
2
,
Mahasweta Gooptu
2
,
Rizwan Romee
2
,
Sarah Nikiforow
2
,
Joseph H Antin
2
,
Jerome Ritz
2
,
Robert J Soiffer
2
,
Catherine J Wu
2
,
Jennifer R Brown
4
Affiliations
1
Department of Data Science, Dana Farber Cancer Institute, Harvard School of Public Health, Boston. htkimc@jimmy.harvard.edu.
2
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston.
3
Duke Cancer Institute, Duke Medical School, Durham.
4
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston. jennifer_brown@dfci.harvard.edu.
PMID:
34435483
PMCID:
PMC8634179
DOI:
10.3324/haematol.2021.279033
No abstract available
Publication types
Research Support, N.I.H., Extramural
MeSH terms
Cell Transformation, Neoplastic
Hematopoietic Stem Cell Transplantation*
Humans
Leukemia, Lymphocytic, Chronic, B-Cell*
Lymphoma, Large B-Cell, Diffuse*
Grants and funding
P01 CA229092/CA/NCI NIH HHS/United States